What Happened
A pharmacist who worked at three different pharmacies in Mason City, Iowa, over a fifteen-year span diverted a wide range of controlled substances for her own use by creating fraudulent prescriptions in real patients' names.
Employed at the pharmacies from 2008 to 2023, she diverted controlled substances including codeine, phentermine, alprazolam, clonazepam, lorazepam, pregabalin, and tramadol. She created unauthorized prescriptions and falsified prescription records and inventory in the names of existing patients, primarily when the pharmacy was closed, filled those prescriptions herself, paid for them, and took them for her own personal use.
She pleaded guilty on February 7, 2025 to one count of acquiring a controlled substance by means of misrepresentation, fraud, deception, and subterfuge. She was sentenced on June 17, 2025 to one month in federal prison, followed by a one-year term of supervised release.
What Went Wrong
A pharmacist with legitimate authority to fill prescriptions was able to generate and fill fraudulent prescriptions in real patients' names for years. Key failure points:
- Real patient identities were usable without their knowledge. Because prescriptions were created in existing patients' names, a surface-level check of "is this a real patient" would not have caught the fraud — the patients simply never knew prescriptions had been filled in their name.
- After-hours activity was not independently reviewed. Fraudulent prescriptions were primarily created and filled when the pharmacy was closed, suggesting after-hours system access and transactions were not reconciled against staffing schedules or flagged for review.
- A pharmacist's own transactions were not subject to independent verification. As pharmacist, she had the authority to both create and fill prescriptions, with no second pharmacist or technician required to verify prescriptions tied to her own purchases.
- Multi-year pattern across multiple employers. The scheme spanned three different pharmacies and roughly fifteen years, indicating no cross-employer prescription monitoring program (PDMP) review flagged the pattern earlier.
How It Could Have Been Prevented
- Require independent pharmacist or technician verification for any prescription filled and purchased by a pharmacist employee, rather than allowing self-verification.
- Reconcile after-hours system access and prescription fills against staff schedules, and flag any activity that occurs while the pharmacy is officially closed.
- Periodically audit a sample of filled prescriptions against prescriber records and contact patients to confirm they requested and received the medication.
- Query state prescription drug monitoring program (PDMP) data for patterns tied to pharmacy staff, not just prescribers, and review discrepancies promptly.
- Run regular controlled-substance inventory reconciliation independent of the staff responsible for day-to-day dispensing.
Related Guidance
- Pharmacy Self-Assessment Checklist — Pharmacy-specific self-assessment covering staff controls and recordkeeping.
- Corresponding Responsibility Guide — Pharmacist obligations to verify legitimacy of prescriptions before dispensing.
- 15 Red Flags of Drug Diversion — Behavioral and recordkeeping indicators of diversion by pharmacy staff.
- Controlled Substance Inventory Guide — Reconciliation, cycle counts, and biennial inventory requirements.
- Investigation Playbook — How to run an internal diversion investigation when staff or product integrity is questioned.